Prashant Pandey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Prashant Pandey has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Divya Setya
Department of transfusion medicine, histocompatibility and molecular biology, Jaypee Hospital, Noida, India
17 shared publications Shweta Ranjan
Department of Transfusion Medicine, Histocompatibility and Molecular Biology, Jaypee hospital, Sector-128, Noida-201304, India
13 shared publicationsSupriya Kumari
Department of Transfusion Medicine & Transplant Immunology Jaypee Hospital Noida India
13 shared publicationsDivya Setya
Department of Transfusion Medicine, Histocompatibility and Molecular Biology, Jaypee hospital, Sector-128, Noida-201304, India
11 shared publicationsPraveen Kumar
Department of Transfusion Medicine & Transplant Immunology Jaypee hospital Sector‐128 Noida 201304 India
7 shared publicationsMukesh Kumar Singh
Department of Transfusion Medicine, Jaypee Hospital, Noida, Uttar Pradesh, India
6 shared publications
Latest Publications
- 22 December 2024
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 39 (6) , e70003
I‐JAMM (II)—Therapeutic Apheresis Practices in Preconditioning of ABO‐Incompatible Kidney and Liver Transplants in India
ABO‐incompatible transplantations are increasingly gaining relevance with advancements in therapeutic modalities, thus allowing patients to receive timely solid organ transplants. Therapeutic apheresis (TA) procedures remain instrumental as a preconditioning measure to enable such transplants. This survey was undertaken to find out current trends and practices of TA across major transplant centers in India. The survey was drafted by a working group of transfusion and transplant immunology specialists from six different centers in India. Data were obtained via the use of an online questionnaire. Results were categorized into eight categories: hospital information, range of titers for preconditioning, considerations prior to starting TA, TA procedure details, role of pharmacotherapy in TA, policy for reuse of columns, risk of rebound, and the role of transfusion medicine specialists. The survey highlighted the modalities as well as the methodologies of various TA procedures used across different major transplant centers in India. With the increase in ABO‐incompatible kidney and liver transplants across the country, the role of transfusion medicine and transplant immunology specialists have become vital in preconditioning regimes enabling the viability and success of such transplants. This was a unique survey that provided us a snapshot of current trends and practices of TA in preconditioning of patients for ABO‐incompatible transplants in India.
- 22 December 2024
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 39 (6) , e70003
I‐JAMM (II)—Therapeutic Apheresis Practices in Preconditioning of ABO‐Incompatible Kidney and Liver Transplants in India
ABO‐incompatible transplantations are increasingly gaining relevance with advancements in therapeutic modalities, thus allowing patients to receive timely solid organ transplants. Therapeutic apheresis (TA) procedures remain instrumental as a preconditioning measure to enable such transplants. This survey was undertaken to find out current trends and practices of TA across major transplant centers in India. The survey was drafted by a working group of transfusion and transplant immunology specialists from six different centers in India. Data were obtained via the use of an online questionnaire. Results were categorized into eight categories: hospital information, range of titers for preconditioning, considerations prior to starting TA, TA procedure details, role of pharmacotherapy in TA, policy for reuse of columns, risk of rebound, and the role of transfusion medicine specialists. The survey highlighted the modalities as well as the methodologies of various TA procedures used across different major transplant centers in India. With the increase in ABO‐incompatible kidney and liver transplants across the country, the role of transfusion medicine and transplant immunology specialists have become vital in preconditioning regimes enabling the viability and success of such transplants. This was a unique survey that provided us a snapshot of current trends and practices of TA in preconditioning of patients for ABO‐incompatible transplants in India.
- Open Access
- 27 March 2024
- Published by Sciencedomain International
- Vol. 7 (1) , 39-54
Comparative Evaluation of the Effect of DTT Treatment and Heat Inactivation on ABO Isoagglutinin Titers
Background and aims: DTT treatment and heat inactivation are the two common methods used for removing the interference of IgM antibodies which can affect the accuracy of IgG measurements. By comparing the effects of these treatments on ABO isoagglutinin titers using two different techniques of titration namely conventional test tube technique (CTT) and column agglutination technique (CAT), the study aims to determine which method is more effective or suitable for this purpose. Materials and methods: Conducted between October 2019 to March 2020, this was a prospective, observational study which included A, B and O group donors. Each donor’s serum was treated with DTT and heat. Titrations were performed by CTT and CAT both before and after treatment. Results: A total of 300 whole blood donors participated in this study; 100 each for group A, B and O. Anti-A and anti-B IgG titers of group O individuals were higher than corresponding titers of non-O individuals. Anti-A titers in group O individuals were slightly higher than anti-B titers, whereas anti-A and anti-B titers from non-O individuals were found to be similar. Heat treated titers were higher than DTT treated titers. Median IgG titers were higher than median IgM titers. Group O titers were higher than non-O titers. Conclusion: DTT treatment was more effective than heat inactivation in terms of efficiently eliminating IgM activity. This study provides insights into the optimal methods for diminishing interference and obtaining accurate measurements of ABO IgG titers, which are crucial for various medical and research applications
- 27 March 2024
- Published by Sciencedomain International
- Vol. 7 (1) , 39-54
Open AccessComparative Evaluation of the Effect of DTT Treatment and Heat Inactivation on ABO Isoagglutinin Titers
Background and aims: DTT treatment and heat inactivation are the two common methods used for removing the interference of IgM antibodies which can affect the accuracy of IgG measurements. By comparing the effects of these treatments on ABO isoagglutinin titers using two different techniques of titration namely conventional test tube technique (CTT) and column agglutination technique (CAT), the study aims to determine which method is more effective or suitable for this purpose. Materials and methods: Conducted between October 2019 to March 2020, this was a prospective, observational study which included A, B and O group donors. Each donor’s serum was treated with DTT and heat. Titrations were performed by CTT and CAT both before and after treatment. Results: A total of 300 whole blood donors participated in this study; 100 each for group A, B and O. Anti-A and anti-B IgG titers of group O individuals were higher than corresponding titers of non-O individuals. Anti-A titers in group O individuals were slightly higher than anti-B titers, whereas anti-A and anti-B titers from non-O individuals were found to be similar. Heat treated titers were higher than DTT treated titers. Median IgG titers were higher than median IgM titers. Group O titers were higher than non-O titers. Conclusion: DTT treatment was more effective than heat inactivation in terms of efficiently eliminating IgM activity. This study provides insights into the optimal methods for diminishing interference and obtaining accurate measurements of ABO IgG titers, which are crucial for various medical and research applications
- Open Access
- 1 July 2023
- Published by Jaypee Brothers Medical Publishing in Global Journal of Transfusion Medicine
- Vol. 8 (2) , 186-189
Correlation between Hepatitis B Viral Load and Hepatitis B Surface Antigen Levels in Asymptomatic Seropositive Blood Donors
Background and Objectives: Correlation has been shown between hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) levels in different patient categories. However, this has not been studied for donors. The aim of this study was to study the relationship between HBV DNA levels and E ratio obtained for HBsAg testing by chemiluminescence immunoassay (CLIA) performed on donor samples. Methods: A prospective, observational study was conducted in the department of transfusion medicine at a large tertiary health-care setup in North India from 2017 to 2021. Serological testing for HBV included HBsAg testing by CLIA. All reactive samples were tested in duplicate by electro CLIA (eCLIA). All samples found to be reactive in all three tests were then tested by a rapid diagnostic test and quantitative polymerase chain reaction. Results: During the study duration, 251 donors were found to be reactive for HBsAg by CLIA and eCLIA in screening. Of these 251, HBV DNA could not be detected in 85 (33.86%) samples, whereas in rest 166 (66.14%) samples, HBV DNA was detected. Mean E ratio for CLIA for all 251 samples was 5177.45, whereas mean viral copies detected were 19645858.66. The correlation for all 251 samples was found to be weak negative. The correlation for sero-reactive samples with the presence of HBV DNA was also found to be weak negative. Conclusion: In conclusion, we found significant but weak correlation between HBsAg results obtained by CLIA and HBV DNA levels for blood donors. The measurement of HBV DNA level is necessary for all apparently healthy donors coming for blood donation and testing reactive for HBsAg in screening assays.
- 1 July 2023
- Published by Jaypee Brothers Medical Publishing in Global Journal of Transfusion Medicine
- Vol. 8 (2) , 186-189
Open AccessCorrelation between Hepatitis B Viral Load and Hepatitis B Surface Antigen Levels in Asymptomatic Seropositive Blood Donors
Background and Objectives: Correlation has been shown between hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) levels in different patient categories. However, this has not been studied for donors. The aim of this study was to study the relationship between HBV DNA levels and E ratio obtained for HBsAg testing by chemiluminescence immunoassay (CLIA) performed on donor samples. Methods: A prospective, observational study was conducted in the department of transfusion medicine at a large tertiary health-care setup in North India from 2017 to 2021. Serological testing for HBV included HBsAg testing by CLIA. All reactive samples were tested in duplicate by electro CLIA (eCLIA). All samples found to be reactive in all three tests were then tested by a rapid diagnostic test and quantitative polymerase chain reaction. Results: During the study duration, 251 donors were found to be reactive for HBsAg by CLIA and eCLIA in screening. Of these 251, HBV DNA could not be detected in 85 (33.86%) samples, whereas in rest 166 (66.14%) samples, HBV DNA was detected. Mean E ratio for CLIA for all 251 samples was 5177.45, whereas mean viral copies detected were 19645858.66. The correlation for all 251 samples was found to be weak negative. The correlation for sero-reactive samples with the presence of HBV DNA was also found to be weak negative. Conclusion: In conclusion, we found significant but weak correlation between HBsAg results obtained by CLIA and HBV DNA levels for blood donors. The measurement of HBV DNA level is necessary for all apparently healthy donors coming for blood donation and testing reactive for HBsAg in screening assays.
- Open Access
- 1 July 2023
- Published by Medknow in Indian Journal of Transplantation
- Vol. 17 (3) , 316-320
Transfusion Support in the First 100 Days of Allogeneic, Matched, Related Hematopoietic Stem Cell Transplant
Export Background: Patients receiving hematopoietic stem-cell transplantation (HSCT) require extensive transfusion support until red blood cell (RBC) and platelet engraftment occurs. The present study was planned to assess the trend of blood component transfusion in the first 100 days of ABO-compatible (ABOc) and ABO-incompatible (ABOi) allogeneic matched, related HSCT. Materials and Methods: This was a prospective study conducted in the department of transfusion medicine at a large tertiary health-care center between 2016 and 2019. Data of component-wise transfusion from the day of transplant to 100 days posttransplant were collected in all allogeneic matched, related peripheral blood HSCT recipients. Results: During the study duration, there were 62 matched, related HSCT. Of these, 38 were ABOc HSCT, and 24 were ABOi HSCT. The mean CD34+ cell dose harvested by apheresis was 7.7 and 6.2 million/kg for ABOc and ABOi categories, respectively. The most common component transfused was platelets (9.15 mean random donor platelet concentrates [RDPCs] units, 4.45 mean single donor platelet concentrates [SDPCs] units issued), followed by red cells (6.9 mean RBC units issued), with fresh frozen plasma (FFP) (3.2 mean FFP units issued) being the least frequently requested component. The mean number of red cells, RDPC, SDPC, and FFP issued for transfusion in the ABOc category were 7.1, 8.7, 5.5, and 2.3, respectively, while it was 6.7, 9.6, 3.4, and 4.1 in ABOi category, respectively. The component-wise difference in the number of units transfused in the first 100 days was not found to be statistically significant (P < 0.05) between the two categories. Conclusions: Contrary to the usual belief that ABOi transplants require more transfusions, the transfusion practices at the present center did not show a significant difference in component-wise transfusions between the two categories. A restrictive transfusion strategy was an important measure in reducing the number of transfusions.
- 1 July 2023
- Published by Medknow in Indian Journal of Transplantation
- Vol. 17 (3) , 316-320
Open AccessTransfusion Support in the First 100 Days of Allogeneic, Matched, Related Hematopoietic Stem Cell Transplant
Export Background: Patients receiving hematopoietic stem-cell transplantation (HSCT) require extensive transfusion support until red blood cell (RBC) and platelet engraftment occurs. The present study was planned to assess the trend of blood component transfusion in the first 100 days of ABO-compatible (ABOc) and ABO-incompatible (ABOi) allogeneic matched, related HSCT. Materials and Methods: This was a prospective study conducted in the department of transfusion medicine at a large tertiary health-care center between 2016 and 2019. Data of component-wise transfusion from the day of transplant to 100 days posttransplant were collected in all allogeneic matched, related peripheral blood HSCT recipients. Results: During the study duration, there were 62 matched, related HSCT. Of these, 38 were ABOc HSCT, and 24 were ABOi HSCT. The mean CD34+ cell dose harvested by apheresis was 7.7 and 6.2 million/kg for ABOc and ABOi categories, respectively. The most common component transfused was platelets (9.15 mean random donor platelet concentrates [RDPCs] units, 4.45 mean single donor platelet concentrates [SDPCs] units issued), followed by red cells (6.9 mean RBC units issued), with fresh frozen plasma (FFP) (3.2 mean FFP units issued) being the least frequently requested component. The mean number of red cells, RDPC, SDPC, and FFP issued for transfusion in the ABOc category were 7.1, 8.7, 5.5, and 2.3, respectively, while it was 6.7, 9.6, 3.4, and 4.1 in ABOi category, respectively. The component-wise difference in the number of units transfused in the first 100 days was not found to be statistically significant (P < 0.05) between the two categories. Conclusions: Contrary to the usual belief that ABOi transplants require more transfusions, the transfusion practices at the present center did not show a significant difference in component-wise transfusions between the two categories. A restrictive transfusion strategy was an important measure in reducing the number of transfusions.
- 17 May 2023
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 62 (5) , 103729
Immunohematological challenges in COVID infected patients
- 17 May 2023
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 62 (5) , 103729
Immunohematological challenges in COVID infected patients
- 8 April 2023
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 38 (4) , 463-471
Single center experience of therapeutic plasma exchange in a resource‐constrained setting: A study of trends in scope and complications
Background: Therapeutic apheresis procedures are becoming an increasingly integral part of modern medical practice, be it as a part of therapy or pre‐conditioning regimes for solid organ transplants. In our center, we follow the American Society for Apheresis (ASFA) guidelines for categorizing these procedures. However, lack of a centralized registry for therapeutic apheresis in India, lack of consolidated data as well as a resource‐constrained setting prevent it from being utilized to its full potential.Study Design and Methods: This study was a retrospective analysis of therapeutic plasma exchange (TPE) procedures performed from January 2015 to October 2022 in the Department of Transfusion Medicine at a large tertiary care hospital in North India. All consecutive TPE procedures were included. Overall and specialty‐wise scoring for all patients was performed. Mean scores were calculated.Results: A total of 1434 procedures were performed during the study duration of 7 years. These procedures were performed for 284 different patients. Majority of the procedures were referred from nephrology (895 of 1434, 62.4%), followed by neurology, gastroenterology, and liver transplant teams, hematology, critical care, rheumatology, pediatrics, and internal medicine. Complete response, partial response, and no‐response were observed in 1077 (75.1%), 201 (14%), and 156 (10.9%) procedures respectively. Only 14 procedures reported adverse effects.Discussion: Increasing effectiveness of TPE in a number of procedures and a variety of indications has broadened its scope, while the small number of adverse events, when supervised by trained Transfusion Medicine physicians has made TPE a more viable and safer alternative to other treatment modalities.
- 8 April 2023
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 38 (4) , 463-471
Single center experience of therapeutic plasma exchange in a resource‐constrained setting: A study of trends in scope and complications
Background: Therapeutic apheresis procedures are becoming an increasingly integral part of modern medical practice, be it as a part of therapy or pre‐conditioning regimes for solid organ transplants. In our center, we follow the American Society for Apheresis (ASFA) guidelines for categorizing these procedures. However, lack of a centralized registry for therapeutic apheresis in India, lack of consolidated data as well as a resource‐constrained setting prevent it from being utilized to its full potential.Study Design and Methods: This study was a retrospective analysis of therapeutic plasma exchange (TPE) procedures performed from January 2015 to October 2022 in the Department of Transfusion Medicine at a large tertiary care hospital in North India. All consecutive TPE procedures were included. Overall and specialty‐wise scoring for all patients was performed. Mean scores were calculated.Results: A total of 1434 procedures were performed during the study duration of 7 years. These procedures were performed for 284 different patients. Majority of the procedures were referred from nephrology (895 of 1434, 62.4%), followed by neurology, gastroenterology, and liver transplant teams, hematology, critical care, rheumatology, pediatrics, and internal medicine. Complete response, partial response, and no‐response were observed in 1077 (75.1%), 201 (14%), and 156 (10.9%) procedures respectively. Only 14 procedures reported adverse effects.Discussion: Increasing effectiveness of TPE in a number of procedures and a variety of indications has broadened its scope, while the small number of adverse events, when supervised by trained Transfusion Medicine physicians has made TPE a more viable and safer alternative to other treatment modalities.
- Open Access
- 1 January 2023
- Published by Medknow in Asian Journal of Transfusion Science
- Vol. 17 (1) , 41-47
A prospective observational study to evaluate effect of heat inactivation on ABO titers performed by column agglutination technology and conventional tube technique
BACKGROUND AND AIMS: When determining ABO antibody titers, immunoglobulin G (IgG) antibodies can be masked by immunoglobulin M (IgM) antibodies. Hence, the measurement of actual concentration of IgG requires methods like heat inactivation (HI) of plasma. This study was aimed at determining the effects of HI on IgM and IgG titers performed by conventional tube technique (CTT) and column agglutination technique (CAT). MATERIALS AND METHODS: This was a prospective, observational study conducted from October 2019 to March 2020. All consecutive A, B, and O group donors who gave consent for participation were included. All samples were consecutively tested by CTT and CAT, before and after HI (pCTT, pCAT). RESULTS: A total of 300 donors were included. IgG titers were found to be more than IgM titers. For group O, IgG titer results were higher for both anti-A and anti-B compared to group A and B. For group A, B, and O, pretreatment results were higher than posttreatment IgG titer results. Median anti-A titers were similar to median anti-B titers across all categories. Median IgM and IgG titers were higher for group O individuals than nongroup O individuals. There was reduction in IgG and IgM titers after HI of plasma. One log reduction in median titers was observed when ABO titers were performed by CAT and CTT. CONCLUSION: There is one log difference between median antibody titers estimated using heat inactivated and nonheat inactivated plasma. The use of HI for ABO isoagglutinin titer estimation can be considered in low resource settings.
- 1 January 2023
- Published by Medknow in Asian Journal of Transfusion Science
- Vol. 17 (1) , 41-47
Open AccessA prospective observational study to evaluate effect of heat inactivation on ABO titers performed by column agglutination technology and conventional tube technique
BACKGROUND AND AIMS: When determining ABO antibody titers, immunoglobulin G (IgG) antibodies can be masked by immunoglobulin M (IgM) antibodies. Hence, the measurement of actual concentration of IgG requires methods like heat inactivation (HI) of plasma. This study was aimed at determining the effects of HI on IgM and IgG titers performed by conventional tube technique (CTT) and column agglutination technique (CAT). MATERIALS AND METHODS: This was a prospective, observational study conducted from October 2019 to March 2020. All consecutive A, B, and O group donors who gave consent for participation were included. All samples were consecutively tested by CTT and CAT, before and after HI (pCTT, pCAT). RESULTS: A total of 300 donors were included. IgG titers were found to be more than IgM titers. For group O, IgG titer results were higher for both anti-A and anti-B compared to group A and B. For group A, B, and O, pretreatment results were higher than posttreatment IgG titer results. Median anti-A titers were similar to median anti-B titers across all categories. Median IgM and IgG titers were higher for group O individuals than nongroup O individuals. There was reduction in IgG and IgM titers after HI of plasma. One log reduction in median titers was observed when ABO titers were performed by CAT and CTT. CONCLUSION: There is one log difference between median antibody titers estimated using heat inactivated and nonheat inactivated plasma. The use of HI for ABO isoagglutinin titer estimation can be considered in low resource settings.
- Open Access
- 1 January 2023
- Published by Medknow in Indian Journal of Transplantation
- Vol. 17 (1) , 90-96
Can Donor Demography or Anthropometry be Used as a Screening Tool for Identifying Potential Low ABO-Titer Plasma?
Background and Aims: Titration is a time-consuming procedure even when automated. The aim of the present study was to identify the variation in ABO titers with donor characteristics in Group O individuals. Materials and Methods: This was a prospective, observational study conducted from January 2019 to March 2020. All consecutive O group donors were included. All samples were tested by conventional tube technique (CTT). Demographic and anthropometric details of the donors such as gender, age, religion, height, weight, first-time/repeat donor, and state of residence were recorded. The high-titer group included individuals with anti-A and anti-B ≥128, and the low-titer group included individuals with anti-A and anti-B 2 (89.95%), and first-time donors (68.4%). The donor age, height, weight, BMI, and body surface area were found to have a weak correlation with anti-A and anti-B titers performed by CTT. The correlation between female and male gender was poor in high- as well as low-titer category. Conclusion: A definite variation in antibody titers is seen with a change in donor demographics and anthropometrics. However, none of the variables helps as a screening tool for identifying the North Indian healthy donors who possess a high or low titer.
- 1 January 2023
- Published by Medknow in Indian Journal of Transplantation
- Vol. 17 (1) , 90-96
Open AccessCan Donor Demography or Anthropometry be Used as a Screening Tool for Identifying Potential Low ABO-Titer Plasma?
Background and Aims: Titration is a time-consuming procedure even when automated. The aim of the present study was to identify the variation in ABO titers with donor characteristics in Group O individuals. Materials and Methods: This was a prospective, observational study conducted from January 2019 to March 2020. All consecutive O group donors were included. All samples were tested by conventional tube technique (CTT). Demographic and anthropometric details of the donors such as gender, age, religion, height, weight, first-time/repeat donor, and state of residence were recorded. The high-titer group included individuals with anti-A and anti-B ≥128, and the low-titer group included individuals with anti-A and anti-B 2 (89.95%), and first-time donors (68.4%). The donor age, height, weight, BMI, and body surface area were found to have a weak correlation with anti-A and anti-B titers performed by CTT. The correlation between female and male gender was poor in high- as well as low-titer category. Conclusion: A definite variation in antibody titers is seen with a change in donor demographics and anthropometrics. However, none of the variables helps as a screening tool for identifying the North Indian healthy donors who possess a high or low titer.
- Open Access
- 1 January 2023
- Published by Medknow in Indian Journal of Transplantation
- Vol. 17 (1) , 82-89
Comparative Evaluation of Titer Estimation of ABO Isoagglutinins using Three Different Methods
Background and Aims: While automation has the advantage of objectivity, ease of use, and reproducibility with well-defined end points of agglutination reaction, standardization of these methods has still not been possible. The aim of the present study was to compare results obtained by manual conventional test tube technique (CTT) with semi-automated, column agglutination technique (CAT), and fully automated hemagglutination/solid-phase red cell adherence (HA/SPRCA) by calculating and comparing correlation and median immunoglobulin M (IgM) and immunoglobulin G (IgG) titer. Materials and Methods: This was a prospective, observational study conducted from October 2019 to March 2020. All consecutive A, B, and O group donors who consented to participate were included in the study. All samples were consecutively tested by CTT, CAT, and HA/SPRCA. Results: A total of 300 (100 each from A, B, and O blood groups) donors were included. IgG titers were higher than IgM titers in most group O individuals. This difference was more evident with the use of CAT. The correlation between CTT and CAT was found to be strong, whereas the correlation between CTT and HA/SPRCA was found to be variable for anti-A and anti-B IgG and IgM titers. When measured by CTT and CAT, median anti-A and anti-B titer results for group O individuals were similar. Anti-A and anti-B median titer results obtained by CTT and CAT for group A and B individuals were also similar. Conclusion: Semi-automated method (CAT) shows higher ability in detecting ABO isoagglutinins than the manual method (CTT) and automated method (HA/SPRCA). These methods cannot be used interchangeably.
- 1 January 2023
- Published by Medknow in Indian Journal of Transplantation
- Vol. 17 (1) , 82-89
Open AccessComparative Evaluation of Titer Estimation of ABO Isoagglutinins using Three Different Methods
Background and Aims: While automation has the advantage of objectivity, ease of use, and reproducibility with well-defined end points of agglutination reaction, standardization of these methods has still not been possible. The aim of the present study was to compare results obtained by manual conventional test tube technique (CTT) with semi-automated, column agglutination technique (CAT), and fully automated hemagglutination/solid-phase red cell adherence (HA/SPRCA) by calculating and comparing correlation and median immunoglobulin M (IgM) and immunoglobulin G (IgG) titer. Materials and Methods: This was a prospective, observational study conducted from October 2019 to March 2020. All consecutive A, B, and O group donors who consented to participate were included in the study. All samples were consecutively tested by CTT, CAT, and HA/SPRCA. Results: A total of 300 (100 each from A, B, and O blood groups) donors were included. IgG titers were higher than IgM titers in most group O individuals. This difference was more evident with the use of CAT. The correlation between CTT and CAT was found to be strong, whereas the correlation between CTT and HA/SPRCA was found to be variable for anti-A and anti-B IgG and IgM titers. When measured by CTT and CAT, median anti-A and anti-B titer results for group O individuals were similar. Anti-A and anti-B median titer results obtained by CTT and CAT for group A and B individuals were also similar. Conclusion: Semi-automated method (CAT) shows higher ability in detecting ABO isoagglutinins than the manual method (CTT) and automated method (HA/SPRCA). These methods cannot be used interchangeably.